Q: Hi Peter,

I am researching some companies in the medical aesthetics space (INMD, CUTR, VERO, AGN, EOLS) and was wondering in this space, what multiple do companies typically trade at from a few different key metrics such as price to sales, P/E ratio, and any other metrics that you feel would be relevant to this space from a valuation perspective? Thanks.

Q: On oct 1/19 you answered a question for Scott re agn/Abbie shares
With the price of agn today at $187 would you still hold agn till deal is done or sell and look for better opportunities
My cost on agn is $186
Thanks

Q: Thank you for your previous response to my question regarding these 2 stocks. I just want to make sure I completely understand your advice: 1) HLTH - My understanding is that my only hope to extracting any value out of this is to wait and see if the stock reappears on the OTC. How long would you suggest is a reasonable amount of time to wait to see if this is going to happen before giving up on the stock having any tradeable value (in my mind $.10 on the $1 is better than nothing)? If it goes OTC will it reappear on my Waterhouse account notifying me of the relisting or is there a place I can periodically search to see if it reappears on the OTC? In the event that I wait a "reasonable" amount of time and it is still not trading on the OTC I can see the merit of gifting the shares to Waterhouse to get the tax write off in the cash account ...... however it seems I would be best to just leave it in the registered accounts as there is no value in gifting them. correct? 2) AGN - you suggested that I tender the AGN shares for ABBV shares and cash........ I assume you meant don't sell the AGN shares on the open market (because of the current discount) and wait until the deal is done and this tendering of shares to the offer will happen automatically....... or do I need to provide instructions to the broker?

Thank you

Scott